Median time to progression in BPI-SF pain at its worst was 57 months ( 95 % CI 56-57 ) in the enzalutamide group and 56 months ( 54-56 ) in the placebo group ( HR 062 [ 95 % CI 053-074 ] ; p < 00001 ) .